Anvisa allows import of Covaxin, Sputnik V into Brazil, but conditions apply Press Trust of India Jun 5, 2021 According to Anvisa's approval, Brazil is expected to receive four million doses of Covaxin initially
Biocon Pharma joins hands with Libbs Farmaceutica to launch generic medicines in Brazil EP News Bureau Mar 29, 2021 Biocon Pharma will be responsible for drug development and manufacturing of the medicines, while Libbs will import, distribute and…
Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN EP News Bureau Feb 26, 2021 It has signed an agreement for the delivery of COVAXIN during Q2 and Q3 2021
Beyond highly developed pharma markets! Wild card access to less explored, high entry barrier… Sameer Kolhe Oct 7, 2020 Sameer Kolhe, President, Maypharm Life Sciences highlights that COVID-19 brings some ‘challenging’ markets within reach for the…
Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate Reuters Aug 18, 2020 The Johnson & Johnson vaccine candidate is the fourth to be approved for human trials in Brazil
Number of US COVID-19 clinical trials surpasses China: GlobalData EP News Bureau Jul 28, 2020 Clinical trials in India also growing at a higher rate, and the country is now in fourth place for COVID-19 trials
Brazil approves human trials for third COVID-19 vaccine in collaboration with Pfizer, BioNTech Reuters Jul 22, 2020 The country is also scrambling to secure supplies of potential vaccines, in case they are proven successful
Brazil to test Sinovac’s potential vaccine against COVID-19 in six states Reuters Jul 2, 2020 The agreement with Sinovac includes not only trials but also the transference of technology to produce the coronavirus vaccine…
Brazil signs agreement to produce AstraZeneca’s COVID-19 vaccine candidate Reuters Jun 28, 2020 The country will initially produce some 30 million doses of the vaccine
Brazil nears deal to produce Oxford coronavirus vaccine Reuters Jun 24, 2020 Human clinical trials in Brazil for the potential vaccine started this weekend with 3,000 people in Sao Paulo and Rio de Janeiro